California-based Medical Tactile, Inc. (MTI) has announced the start of commercial
sales of its first product, the SureTouch Visual Mapping System for electronically
documenting clinical breast exam results. The system has been cleared for commercial
sale by the U.S. Food and Drug Administration as an adjunct device for performing
and documenting clinical breast exams.
Medical Technology Business Europe